Lipoxin A4

Lipoxin a4 is a lipid of Fatty Acyls (FA) class. Lipoxin a4 is associated with abnormalities such as Asthma, Cystic Fibrosis, Pneumonia, Obesity and Septicemia. The involved functions are known as Inflammation, Signal, Signal Transduction, Regulation and Metabolic Inhibition. Lipoxin a4 often locates in Immune system, Blood, soluble, Extracellular and Splenic Tissue. The associated genes with Lipoxin A4 are FPR2 gene, Homologous Gene, SAA1 gene, Trp-Lys-Tyr-Met-Val-Met and Annexin 1. The related lipids are Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Lipoxin A4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Lipoxin A4?

Lipoxin A4 is suspected in Asthma, Cystic Fibrosis, Chagas Cardiomyopathy, Pneumonia, Obesity, Septicemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Lipoxin A4

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lung Diseases D008171 37 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Per page 10 20 50 100 | Total 53

PubChem Associated disorders and diseases

What pathways are associated with Lipoxin A4

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Lipoxin A4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Lipoxin A4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Lipoxin A4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Lipoxin A4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Lipoxin A4?

Knock-out

Knock-out are used in the study 'Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice.' (Ortiz-Muñoz G et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Lipoxin A4

Download all related citations
Per page 10 20 50 100 | Total 639
Authors Title Published Journal PubMed Link
Mustafa M et al. Resolvin D1 protects periodontal ligament. 2013 Am. J. Physiol., Cell Physiol. pmid:23864609
Lee HJ et al. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. 2013 Int. J. Biochem. Cell Biol. pmid:24120851
Das UN Lipoxins, resolvins, and protectins in the prevention and treatment of diabetic macular edema and retinopathy. 2013 Nutrition pmid:22677359
Abdelmoaty S et al. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. 2013 PLoS ONE pmid:24086560
Canny GO and Lessey BA The role of lipoxin A4 in endometrial biology and endometriosis. 2013 Mucosal Immunol pmid:23485944
Xiong J et al. Lipoxin A4 blocks embryo implantation by controlling estrogen receptor α activity. 2013 Reproduction pmid:23426803
Divangahi M et al. Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis. 2013 Adv. Exp. Med. Biol. pmid:23468106
Wang Q et al. Lipoxin A(4) activates alveolar epithelial sodium channel, Na,K-ATPase, and increases alveolar fluid clearance. 2013 Am. J. Respir. Cell Mol. Biol. pmid:23470626
Peebles RS A new horizon in asthma: inhibiting ILC function. 2013 Sci Transl Med pmid:23447016
Gori I et al. Augmented epithelial multidrug resistance-associated protein 4 expression in peritoneal endometriosis: regulation by lipoxin A(4). 2013 Fertil. Steril. pmid:23472950
Kirkby NS et al. Aspirin-triggered 15-epi-lipoxin A4 predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test. 2013 FASEB J. pmid:23792301
Wu L et al. Lipoxin A4 ameliorates cerebral ischaemia/reperfusion injury through upregulation of nuclear factor erythroid 2-related factor 2. 2013 Neurol. Res. pmid:23880501
Endo H [Resolving factors of inflammation - a bridge between innate immunity and adaptive immunity]. 2013 Nihon Rinsho Meneki Gakkai Kaishi pmid:23812073
Sordi R et al. Dual role of lipoxin A4 in pneumosepsis pathogenesis. 2013 Int. Immunopharmacol. pmid:23816538
Park SW et al. Apolipoprotein A1 potentiates lipoxin A4 synthesis and recovery of allergen-induced disrupted tight junctions in the airway epithelium. 2013 Clin. Exp. Allergy pmid:23889245
Zhang G et al. Resolution of PMA-induced skin inflammation involves interaction of IFN-γ and ALOX15. 2013 Mediators Inflamm. pmid:23818745
Chen XQ et al. Lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against hypoxia/reoxygenation injury via p38 MAPK activation and Nrf2/ARE complex. 2013 PLoS ONE pmid:23826208
Xia J et al. Roles of lipoxin A4 in preventing paracetamol-induced acute hepatic injury in a rabbit model. 2013 Inflammation pmid:23851615
Chen XQ et al. Involvement of K+ channel-dependant pathways in lipoxin A4-induced protective effects on hypoxia/reoxygenation injury of cardiomyocytes. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:23602847
Planagumà A et al. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function. 2013 Clin. Exp. Immunol. pmid:23607720
Shryock N et al. Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain. 2013 PLoS ONE pmid:23613965
Hanson J et al. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin Aâ‚„. 2013 Biochem. Pharmacol. pmid:23643932
Liang S et al. [Change of serum myeloperoxidase and lipoxin A4 level in coronary heart disease patients with anxiety and/or depression]. 2013 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:23645243
Wu B et al. Lipoxin A(4) promotes more complete inflammation resolution in sepsis compared to stable lipoxin A(4) analog. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:23688707
Molina-Berríos A et al. Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect. 2013 PLoS Negl Trop Dis pmid:23638194
Das UN Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:23295193
Wang C et al. IFN-γ-mediated downregulation of LXA4 is necessary for the maintenance of nonresolving inflammation and papilloma persistence. 2013 Cancer Res. pmid:23319805
Luo CL et al. Lipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injury. 2013 Brain Res. pmid:23370001
Tsai WH et al. Plasma levels in sepsis patients of annexin A1, lipoxin A4, macrophage inflammatory protein-3a, and neutrophil gelatinase-associated lipocalin. 2013 J Chin Med Assoc pmid:23769883
Barnig C and Levy BD Lipoxin A4: a new direction in asthma therapy? 2013 Expert Rev Clin Immunol pmid:23730877
Brancaleone V et al. A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. 2013 Blood pmid:23733341
Costa ES et al. Involvement of formyl peptide receptors in the stimulatory effect of crotoxin on macrophages co-cultivated with tumour cells. 2013 Toxicon pmid:23998941
Lv W et al. Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury. 2013 Exp. Biol. Med. (Maywood) pmid:24000382
Zhao Q et al. Lipoxin a4 preconditioning and postconditioning protect myocardial ischemia/reperfusion injury in rats. 2013 Mediators Inflamm. pmid:23956501
Moreno C et al. Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity. 2013 J. Immunol. pmid:24249731
Lin F et al. A synthetic analog of lipoxin A4 partially alleviates dexamethasone-induced fetal growth restriction in rats. 2013 Placenta pmid:23910525
Zhao QF et al. [Effects of lipoxinA4 on endoplasmic reticulum stress during myocardial ischemia reperfusion injury in rats]. 2013 Zhonghua Yi Xue Za Zhi pmid:23863683
Meng H et al. Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro. 2013 Lipids Health Dis pmid:24168453
Medeiros R et al. Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice. 2013 Am. J. Pathol. pmid:23506847
Xu Z et al. Spontaneous miscarriages are explained by the stress/glucocorticoid/lipoxin A4 axis. 2013 J. Immunol. pmid:23677469
Buchanan PJ et al. Lipoxin Aâ‚„-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair. 2013 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:23686859
Shimizu S et al. Pro-resolution mediator lipoxin A4 and its receptor in upper airway inflammation. 2013 Ann. Otol. Rhinol. Laryngol. pmid:24358628
Dai J et al. Effects of polyunsaturated fatty acids on the growth of gastric cancer cells in vitro. 2013 Lipids Health Dis pmid:23663688
Weiss GA et al. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. 2013 Lipids Health Dis pmid:23767972
Kazani S et al. Exhaled breath condensate eicosanoid levels associate with asthma and its severity. 2013 J. Allergy Clin. Immunol. pmid:23608729
Gil-Villa AM et al. Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma. 2012 Oct-Nov Prostaglandins Leukot. Essent. Fatty Acids pmid:22974760
Das UN Radiation resistance, invasiveness and metastasis are inflammatory events that could be suppressed by lipoxin A4. 2012 Jan-Feb Prostaglandins Leukot. Essent. Fatty Acids pmid:22014542
Esper L et al. Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. 2012 Am. J. Pathol. pmid:22658486
Pamplona FA et al. Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:23150578
Dakin SG et al. Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease. 2012 PLoS ONE pmid:23155437